Innovative Bispecific Antibody Therapies in Cancer Treatment Emerge as Patent Filings SurgeDublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody & Cancer Patent Landscape Analysis" report ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Although the media and the public are worried about the infectious risks of transfusion, hemovigilance reports show that antigen-antibody reactions are responsible for the vast majority of acute ...

The American Academy of Pediatrics says doctors’ offices can dismiss families from their practice over the question of ...

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

A video of Robert F. Kennedy Jr. in his Senate confirmation hearing repeating a misleading narrative that Black people should ...

In the rapidly advancing field of molecular biology, techniques for studying protein interactions are constantly evolving. Among these, Surface Plasmon Resonance (SPR) stands out as a powerful ...

Esoteric Testing Market Research Report In 2022, the global esoteric testing market was valued at $24.2 billion and projected reach $68.5 b ...

Seasoned Oncology Leader Brings Extensive ADC Expertise to Support Company's New Pipeline MORRISTOWN, N.J., Feb. 18, 2025 /PRNewswire/ -- Aadi Bioscience, Inc.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...